LEAP: learning to prescribe effective and safe treatment combinations for multimorbidity

Y Zhang, R Chen, J Tang, WF Stewart… - proceedings of the 23rd …, 2017 - dl.acm.org
proceedings of the 23rd ACM SIGKDD international conference on knowledge …, 2017dl.acm.org
Managing patients with complex multimorbidity has long been recognized as a difficult
problem due to complex disease and medication dependencies and the potential risk of
adverse drug interactions. Existing work either uses complicated rule-based protocols which
are hard to implement and maintain, or simple statistical models that treat each disease
independently, which may lead to sub-optimal or even harmful drug combinations. In this
work, we propose the LEAP (LEArn to Prescribe) algorithm to decompose the treatment …
Managing patients with complex multimorbidity has long been recognized as a difficult problem due to complex disease and medication dependencies and the potential risk of adverse drug interactions. Existing work either uses complicated rule-based protocols which are hard to implement and maintain, or simple statistical models that treat each disease independently, which may lead to sub-optimal or even harmful drug combinations. In this work, we propose the LEAP (LEArn to Prescribe) algorithm to decompose the treatment recommendation into a sequential decision-making process while automatically determining the appropriate number of medications. A recurrent decoder is used to model label dependencies and content-based attention is used to capture label instance mapping. We further leverage reinforcement learning to fine tune the model parameters to ensure accuracy and completeness. We incorporate external clinical knowledge into the design of the reinforcement reward to effectively prevent generating unfavorable drug combinations. Both quantitative experiments and qualitative case studies are conducted on two real world electronic health record datasets to verify the effectiveness of our solution. On both datasets, LEAP significantly outperforms baselines by up to 10-30% in terms of mean Jaccard coefficient and removes 99.8% adverse drug interactions in the recommended treatment sets.
ACM Digital Library